Department of Endocrinology and Metabolism, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.
Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, National Center for Neurological Disorders, Shanghai, China.
Endocrine. 2022 Nov;78(2):329-342. doi: 10.1007/s12020-022-03155-z. Epub 2022 Aug 10.
Growth hormone-secreting pituitary adenoma (GHPA) is an insidious disease with persistent hypersecretion of growth hormone and insulin-like growth factor 1, causing increased morbidity and mortality. Previous studies have investigated the transcription of GHPA. However, the gene regulatory landscape has not been fully characterized. The objective of our study was to unravel the changes in chromatin accessibility and transcription in GHPA.
Six patients diagnosed with GHPA in the Department of Neurosurgery at Huashan Hospital were enrolled in our study. Primary pituitary adenoma tissues and adjacent normal pituitary specimens with no morphologic abnormalities from these six patients were obtained at surgery. RNA sequencing (RNA-seq) and assay for transposase-accessible chromatin with high-throughput sequencing (ATAC-seq) were applied to investigate the underlying relationship between gene expression and chromatin accessibility changes in GHPA.
Totally, 1528 differential expression genes (DEGs) were identified by transcriptomics analyses, including 725 up-regulated and 803 down-regulated. Further, we obtained 64 significantly DEGs including 10 DEGs were elevated and 54 DEGs were negligibly expressed in tumors tissues. The up-regulated DEGs were mainly involved in terms related to synapse formation, nervous system development and secretory pathway. In parallel, 3916 increased and 2895 decreased chromatin-accessible regions were mapped by ATAC-seq. Additionally, the chromatin accessible changes were frequently located adjacent to transcription factor CTCF and Rfx2 binding site.
Our results are the first to demonstrate the landscape of chromatin accessibility in GHPA, which may contribute to illustrate the underlying transcriptional regulation mechanism of this disease.
生长激素分泌性垂体腺瘤(GHPA)是一种隐匿性疾病,其生长激素和胰岛素样生长因子 1 持续过度分泌,导致发病率和死亡率增加。先前的研究已经调查了 GHPA 的转录。然而,基因调控景观尚未得到充分描述。我们的研究旨在揭示 GHPA 中染色质可及性和转录的变化。
我们招募了华山医院神经外科诊断为 GHPA 的 6 名患者。在手术中获得了这 6 名患者的原发性垂体腺瘤组织和相邻的正常垂体标本,这些标本没有形态异常。应用 RNA 测序(RNA-seq)和高通量测序的转座酶可及染色质分析(ATAC-seq)来研究 GHPA 中基因表达和染色质可及性变化之间的潜在关系。
通过转录组学分析共鉴定出 1528 个差异表达基因(DEGs),包括 725 个上调和 803 个下调。此外,我们获得了 64 个显著差异表达基因,包括 10 个上调和 54 个下调的基因在肿瘤组织中表达。上调的 DEGs 主要涉及与突触形成、神经系统发育和分泌途径相关的术语。同时,通过 ATAC-seq 定位了 3916 个增加的和 2895 个减少的染色质可及区。此外,染色质可及性的变化经常位于转录因子 CTCF 和 Rfx2 结合位点的附近。
我们的研究结果首次证明了 GHPA 中染色质可及性的图谱,这可能有助于阐明该疾病潜在的转录调控机制。